As critics of the pharmaceutical industry have begun floating the idea of banning direct-to-consumer (DTC) pharmaceutical advertising, the media has largely framed it as a crackdown on “Big Pharma.” But beneath the populist gloss lies a dangerous effort to normalize speech restrictions that should alarm anyone who values the First Amendment or fears such tactics spreading to other sectors, such as energy. These same activists have argued that refusing to adopt their preferred climate-friendly green technology will “drive up costs” either from the cost of bad weather damage they attribute to climate change, or by missing out on the “efficiency” benefits that thus far have not come to fruition. The views and opinions expressed in this commentary are those of the author and do not reflect the official position of the Daily Caller News Foundation.
Author: Steve Milloy
Published at: 2025-06-30 20:56:04
Still want to read the full version? Full article
